Print this page Email this page
Users Online: 522
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Contacts Login 
ORIGINAL ARTICLE
Year : 2021  |  Volume : 35  |  Issue : 3  |  Page : 98-102

E-test antifungal susceptibility profile of Candida spp. associated with vulvovaginal candidiasis in patients of Manipur


1 Microbiologist, Manipur Health Services, State Medical Services, Imphal, Manipur, India
2 Department of Obstetrics and Gynaecology, Institute of Bioresources and Sustainable Development, Imphal, Manipur, India
3 Department of Microbial Resources Division, Institute of Bioresources and Sustainable Development, Imphal, Manipur, India
4 Department of Microbiology, Regional Institute of Medical Sciences, Institute of Bioresources and Sustainable Development, Imphal, Manipur, India

Correspondence Address:
Randhir Babu Singh Yendrembam
Microbial Resources Division, Institute of Bioresources and Sustainable Development, Takyelpat, Imphal - 795 001, Manipur
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jms.jms_117_21

Rights and Permissions

Background and Objectives: Vulvovaginal candidiasis (VVC) is one of the most common vaginal infections during fertile period of women. An increase in the prevalence of non-albicans Candida which are resistant to commonly used antifungals has been documented. Therefore, studying the antifungal susceptibility pattern of the causative agents is of great significance in successfully treating the ailment and understanding the local data. Materials and Methods: Forty-six Candida spp. isolated from VVC patients were subjected to antifungal minimum inhibitory concentration testing for itraconazole, fluconazole, and voriconazole using E-test method. Results: Candida albicans and Candida glabrata showed 87.8% and 60% sensitivity, respectively, to itraconazole. Twenty percent of Candida parapsilosis and 40% of C. glabrata were resistant to fluconazole. Voriconazole showed higher sensitivity with 0.013 μg/ml as the minimum concentration to inhibit all Candida spp. C. glabrata noted higher minimum inhibitory concentrations against itraconazole, fluconazole, and voriconazole. Interpretation and Conclusion: Voriconazole is the drug of choice in case of fluconazole treatment failure among VVC.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed608    
    Printed32    
    Emailed0    
    PDF Downloaded81    
    Comments [Add]    

Recommend this journal